Back to all bills
HR 5969119th CongressIn Committee
LABEL Act
Introduced: Nov 7, 2025
Sponsor: Rep. Moore, Barry [R-AL-1] (R-Alabama)
Civil Rights & JusticeHealthcare
Standard Summary
Comprehensive overview in 1-2 paragraphs
The LABEL Act amends the Federal Food, Drug, and Cosmetic Act to mandate specific labeling requirements for abortion-inducing drugs, requiring dispenser name/address and prescriber name on labels while preempting less stringent state regulations and excluding certain medical exceptions like ectopic pregnancy treatment.
Key Points
- 1The legislation requires all abortion-inducing drugs to display the dispenser's full contact information and prescriber's name directly on product labeling as a federal mandate.
- 2It explicitly defines 'abortion-inducing drug' as substances terminating pregnancy while excluding treatments for miscarriage or ectopic pregnancy scenarios.
- 3The bill establishes federal preemption preventing states from enforcing labeling standards less strict than the new national requirements for these medications.
Impact Areas
Pharmaceutical manufacturers producing abortion medicationsHealthcare providers prescribing and dispensing abortion drugsState regulatory agencies overseeing drug compliancePatients accessing medication abortion services
Generated by legislative-analysis-v1 on Nov 13, 2025